Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177372
Status:
COMPLETED
Last Update Posted:
2016-01-29
First Post:
2005-09-12
Brief Title:
Mifepristone and Misoprostol for Fetal Demise
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
Mifepristone and Misoprostol for the Treatment of Early Pregnancy Failure a Pilot Clinical Trial
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MIMID
Brief Summary:
This is a pilot clinical trial to evaluate whether the medical management of early pregnancy failure with mifepristone and misoprostol is an effective and acceptable treatment Subjects with early pregnancy failure receive mifepristone followed 24 hours later by vaginal misoprostol for medical management Subjects then return on study day 3 for a repeat ultrasound to assess passage of pregnancy tissue subjects who still have a gestational sac present at Day 3 receive a second dose of vaginal misoprostol All subjects have a follow-up at Day 15 by phone for those who passed the pregnancy with the first dose of misoprostol and in person for those who received a second dose Questionnaires are administered at the beginning and end of the study to determine acceptability
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None